EK Kruithof - Concepedia

Author

EK Kruithof

Also Known As

E K Kruithof, E K O Kruithof, E K O kruithof, E KO Kruithof, E Kruithof, E. K. O. Kruithof, E. Kruithof, E.K.O Kruithof, E.K.O. KRUITHOF, E.K.O. Kruithof

Publications

3.1K

Citations

H-Index

Concepts

All Affiliations

University Hospital of Lausanne University of Lausanne University Hospital of Geneva KU Leuven Hôtel-Dieu de Paris

About

EK Kruithof is an author at University Hospital of Lausanne specializing in medicine, pharmacology, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	557
2	Health Sciences	1	1	17
3	Natural Sciences	1	1	29
4	Public Health	1	1	21
5	Biochemistry	1	1	31

EK Kruithof

Publications

Citations

H-Index

Page 1

	Year	Citations
Measurement of plasminogen activator inhibitor 1 in biologic fluids with a murine monoclonal antibody-based enzyme-linked immunosorbent assay Margot F. K. Verstreken, EK Kruithof, I. Juhan‐Vague, Blood	1988	531
Demonstration of a fast-acting inhibitor of plasminogen activators in human plasma EK Kruithof, C Tran-Thang, Adriana Ransijn, Blood	1984	379
Fibrinolysis in pregnancy: a study of plasminogen activator inhibitors EK Kruithof, C Trân-Thang, A Gudinchet, Blood	1987	333
Biological and clinical aspects of plasminogen activator inhibitor type 2 EK Kruithof, Mark S. Baker, C. L. Bunn Blood PharmacologyMechanism Of ActionPathologyFibrinolysisClinical Aspects	1995	326
Demonstration of a fast-acting inhibitor of plasminogen activators in human plasma EK Kruithof, C Tran-Thang, A Ransijn, Blood	1984	306
Measurement of plasminogen activator inhibitor 1 in biologic fluids with a murine monoclonal antibody-based enzyme-linked immunosorbent assay Margot F. K. Verstreken, EK Kruithof, I. Juhan‐Vague, Blood	1988	263
Plasminogen activator inhibitor 1: development of a radioimmunoassay and observations on its plasma concentration during venous occlusion and after platelet aggregation EK Kruithof, G Nicolosa, F Bachmann Blood	1987	191
A lifelong bleeding disorder associated with a deficiency of plasminogen activator inhibitor type 1 J Diéval, G. Nguyen, Sylvie Gross, Blood	1991	157
Inhibition of invasion of HT1080 sarcoma cells expressing recombinant plasminogen activator inhibitor 2. Walter E. Laug, Xi‐Peng Cao, Yanbao Yu, PubMed ImmunologyReceptor-bound UrokinaseCancer BiologyCellular PhysiologyTumor Biology	1993	77
Residual plasminogen activator inhibitor activity after venous stasis as a criterion for hypofibrinolysis: a study in 83 patients with confirmed deep vein thrombosis Giang Huong Nguyen, MH Horellou, EK Kruithof, Blood	1988	65

Page 1